These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12556219)

  • 1. Development potential of rifalazil.
    Rothstein DM; Hartman AD; Cynamon MH; Eisenstein BI
    Expert Opin Investig Drugs; 2003 Feb; 12(2):255-71. PubMed ID: 12556219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development potential of rifalazil and other benzoxazinorifamycins.
    Rothstein DM; Shalish C; Murphy CK; Sternlicht A; Campbell LA
    Expert Opin Investig Drugs; 2006 Jun; 15(6):603-23. PubMed ID: 16732714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis.
    Kutlin A; Kohlhoff S; Roblin P; Hammerschlag MR; Riska P
    Antimicrob Agents Chemother; 2005 Mar; 49(3):903-7. PubMed ID: 15728882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infections.
    Rothstein DM; van Duzer J; Sternlicht A; Gilman SC
    Arch Pharm (Weinheim); 2007 Oct; 340(10):517-29. PubMed ID: 17912677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
    Anton PM; O'Brien M; Kokkotou E; Eisenstein B; Michaelis A; Rothstein D; Paraschos S; Kelly CP; Pothoulakis C
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3975-9. PubMed ID: 15388461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifalazil pretreatment of mammalian cell cultures prevents subsequent Chlamydia infection.
    Suchland RJ; Brown K; Rothstein DM; Stamm WE
    Antimicrob Agents Chemother; 2006 Feb; 50(2):439-44. PubMed ID: 16436694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifalazil retains activity against rifampin-resistant mutants of Chlamydia pneumoniae.
    Rothstein DM; Suchland RJ; Xia M; Murphy CK; Stamm WE
    J Antibiot (Tokyo); 2008 Aug; 61(8):489-95. PubMed ID: 18997387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind study comparing single-dose rifalazil with single-dose azithromycin for the empirical treatment of nongonococcal urethritis in men.
    Stamm WE; Batteiger BE; McCormack WM; Totten PA; Sternlicht A; Kivel NM;
    Sex Transm Dis; 2007 Aug; 34(8):545-52. PubMed ID: 17297383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.
    Scarpignato C; Pelosini I
    Chemotherapy; 2005; 51 Suppl 1():36-66. PubMed ID: 15855748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis.
    Dietze R; Teixeira L; Rocha LM; Palaci M; Johnson JL; Wells C; Rose L; Eisenach K; Ellner JJ
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1972-6. PubMed ID: 11408210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparative Insight on the Newly Emerging Rifamycins: Rifametane, Rifalazil, TNP-2092 and TNP-2198.
    Nazli A; He DL; Xu H; Wang ZP; He Y
    Curr Med Chem; 2022; 29(16):2846-2862. PubMed ID: 34365945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil.
    Suchland RJ; Bourillon A; Denamur E; Stamm WE; Rothstein DM
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1120-6. PubMed ID: 15728912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea.
    Garey KW; Salazar M; Shah D; Rodrigue R; DuPont HL
    Ann Pharmacother; 2008 Jun; 42(6):827-35. PubMed ID: 18430792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of rifalazil with oxidant-generating systems of human polymorphonuclear neutrophils.
    Labro MT; Ollivier V; Babin-Chevaye C
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5018-23. PubMed ID: 16304167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatis.
    Xia M; Suchland RJ; Carswell JA; Van Duzer J; Buxton DK; Brown K; Rothstein DM; Stamm WE
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3974-6. PubMed ID: 16127086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and identification of major metabolites of rifalazil in mouse and human.
    Mae T; Konishi E; Hosoe K; Hidaka T
    Xenobiotica; 1999 Nov; 29(11):1073-87. PubMed ID: 10598743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
    Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro time-kill activities of rifalazil, alone and in combination with vancomycin, against logarithmic and stationary cultures of Staphylococcus aureus.
    Osburne MS; Rothstein DM; Farquhar R; Murphy CK
    J Antibiot (Tokyo); 2006 Feb; 59(2):80-5. PubMed ID: 16629407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifalazil.
    Tuberculosis (Edinb); 2008 Mar; 88(2):148-50. PubMed ID: 18486057
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of food on the pharmacokinetics of rifalazil, a novel antibacterial, in healthy male volunteers.
    Chen YX; Cabana B; Kivel N; Michaelis A
    J Clin Pharmacol; 2007 Jul; 47(7):841-9. PubMed ID: 17463218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.